BIONANO GENOMICS, INC.
Profile
Company Names
BIONANO GENOMICS, INC.
BIONANO GENOMICS, INC
BIONANOMATRIX INC
Addresses
9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA 92121
9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA 92121
9640 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA 92121
9640 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA 92121
9640 TOWNE CENTRE DRIVE, SAN DIEGO, CA 92121
3701 MARKET STREET, 4TH FLOOR, PHILADELPHIA, PA 19104
Phone Numbers
(858) 888-7600
(609) 818-0054
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER HEALTH CARE, PHARMACEUTICALS
Year Incorporated:
2007
State Incorporated:
DELAWARE
Total Amount Raised:
$238,431,762.00
Number of Funding Rounds:
12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2024-07-08
$20,000,001.00
$20,000,001.00
$0.00
11
2024-05-24
$20,000,000.00
$20,000,000.00
$0.00
Equity, Debt
10
2023-10-13
$35,000,000.00
$35,000,000.00
$0.00
Debt
9
2021-10-18
$41,850,386.00
$41,850,386.00
$0.00
Equity
8
2019-03-14
$2,500,000.00
$11,500,000.00
$9,000,000.00
Equity
7
2014-09-09
$68,443,451.00
$68,443,451.00
$0.00
Equity
6
2014-06-12
$5,000,500.00
$6,139,997.00
$1,139,497.00
Debt
5
2013-12-11
$15,000.00
$15,000.00
$0.00
4
2013-09-17
$10,001,000.00
$13,663,054.00
$3,662,054.00
Debt
3
2012-06-20
$11,573,201.00
$13,939,494.00
$2,366,293.00
Equity
2
2011-03-15
$23,265,909.00
$23,265,909.00
$0.00
Equity
1
2010-04-14
$782,314.00
$4,000,000.00
$3,217,686.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID
BARKER
DIRECTOR
DARREN
CAI
DIRECTOR
EDWARD
L.
ERICKSON
EXECUTIVE OFFICER, DIRECTOR
BRIAN
HALAK
DIRECTOR
OCEANA THERAPEUTICS, INC.
| ALIMERA SCIENCES INC
| ORAYA THERAPEUTICS INC
| CORTRIA CORP
| GI DYNAMICS, INC.
| TOBIRA THERAPEUTICS, INC.
| CORRIDOR PHARMACEUTICALS, INC.
| KONA MEDICAL, INC.
| NANOTHERA CORP
| BIONANOMATRIX INC
| BIONANO GENOMICS, INC
| WINDMIL THERAPEUTICS, INC.
| SONOTHERA, INC.
| THIRDLAW MOLECULAR, INC.
ALBERT
A.
LUDERER
DIRECTOR
CAMPBELL
MURRAY
DIRECTOR
ALIOS BIOPHARMA INC
| TOKAI PHARMACEUTICALS INC
| AILERON THERAPEUTICS INC
| BIORELIX INC
| EUTHYMICS BIOSCIENCE INC
| AKEBIA THERAPEUTICS, INC.
| AERPIO THERAPEUTICS, INC.
| NEUROVANCE, INC.
| EBI LIFE SCIENCES, INC.
| IMAGINAB, INC.
| GALERA THERAPEUTICS, INC.
| BIONANO GENOMICS, INC
| EUTHYMICS BIOSCIENCE, INC.
| ICEBREAKER HEALTH, INC.
| ANNEXON, INC.
| TSCAN THERAPEUTICS, INC.
| RENOVACOR, INC.
| LIGHTHOUSE PHARMACEUTICALS, INC.
LYNNE
ROLLINS
EXECUTIVE OFFICER
CHRISTOPHER
STEWART
EXECUTIVE OFFICER
JUNFENG
WANG
DIRECTOR
MIKE
WARD
EXECUTIVE OFFICER
QUAN
ZHOU
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
2024-07-08
D
BIOTECHNOLOGY
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Equity, Debt
2024-05-24
D
OTHER HEALTH CARE
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Debt
2023-10-13
D
OTHER HEALTH CARE
LABORATORY ANALYTICAL INSTRUMENTS [3826]
DECLINE TO DISCLOSE
Equity
2021-10-18
D
PHARMACEUTICALS
LABORATORY ANALYTICAL INSTRUMENTS [3826]
NOT APPLICABLE
Equity
2019-03-14

